The hexosamine concentration and output in human pure pancreatic juice in chronic pancreatitis. 1980

H Harada, and M Takeda, and H Yabe, and E Hanafusa, and T Hayashi, and K Kunichika, and F Kochi, and K Mishima, and I Kimura, and T Ubuga

Hexosamine concentration in human pure pancreatic juice was determined during wash-out phase and secretin stimulation phase. Specimens were collected by endoscopic retrograde catheterization of the papilla at one minute intervals for 20 minutes after intravenous injection of secretin (Eisai, 1 U/kg) and for 10 minutes after pancreozymin injection (Boots, 1 U/kg). In suspected and established chronic pancreatitis (calcifying or non-calcifying), hexosamine concentration was significantly raised during both wash-out phase and secretin phase. Hexosamine output was significantly raised in suspected chronic pancreatitis and non-calcifying chronic pancreatitis during both wash-out phase and secretin phase; in calcifying chronic pancreatitis, no significant increase in hexosamine output was noted during both phases because of decreased secretory volume. Significance of these findings was discussed in relation to the pathogenesis of chronic pancreatitis.

UI MeSH Term Description Entries
D010189 Pancreatic Juice The fluid containing digestive enzymes secreted by the pancreas in response to food in the duodenum. Juice, Pancreatic,Juices, Pancreatic,Pancreatic Juices
D010195 Pancreatitis INFLAMMATION of the PANCREAS. Pancreatitis is classified as acute unless there are computed tomographic or endoscopic retrograde cholangiopancreatographic findings of CHRONIC PANCREATITIS (International Symposium on Acute Pancreatitis, Atlanta, 1992). The two most common forms of acute pancreatitis are ALCOHOLIC PANCREATITIS and gallstone pancreatitis. Acute Edematous Pancreatitis,Acute Pancreatitis,Pancreatic Parenchyma with Edema,Pancreatic Parenchymal Edema,Pancreatitis, Acute,Pancreatitis, Acute Edematous,Peripancreatic Fat Necrosis,Acute Edematous Pancreatitides,Acute Pancreatitides,Edema, Pancreatic Parenchymal,Edematous Pancreatitides, Acute,Edematous Pancreatitis, Acute,Fat Necrosis, Peripancreatic,Necrosis, Peripancreatic Fat,Pancreatic Parenchymal Edemas,Pancreatitides, Acute,Pancreatitides, Acute Edematous,Parenchymal Edema, Pancreatic,Peripancreatic Fat Necroses
D002114 Calcinosis Pathologic deposition of calcium salts in tissues. Calcification, Pathologic,Calcinosis, Tumoral,Microcalcification,Microcalcinosis,Pathologic Calcification,Calcinoses,Calcinoses, Tumoral,Microcalcifications,Microcalcinoses,Tumoral Calcinoses,Tumoral Calcinosis
D002766 Cholecystokinin A peptide, of about 33 amino acids, secreted by the upper INTESTINAL MUCOSA and also found in the central nervous system. It causes gallbladder contraction, release of pancreatic exocrine (or digestive) enzymes, and affects other gastrointestinal functions. Cholecystokinin may be the mediator of satiety. Pancreozymin,CCK-33,Cholecystokinin 33,Uropancreozymin
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D006595 Hexosamines AMINO SUGARS created by adding an amine group to a hexose sugar. Hexosamine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000437 Alcoholism A primary, chronic disease with genetic, psychosocial, and environmental factors influencing its development and manifestations. The disease is often progressive and fatal. It is characterized by impaired control over drinking, preoccupation with the drug alcohol, use of alcohol despite adverse consequences, and distortions in thinking, most notably denial. Each of these symptoms may be continuous or periodic. (Morse & Flavin for the Joint Commission of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism: in JAMA 1992;268:1012-4) Alcohol Abuse,Alcoholic Intoxication, Chronic,Ethanol Abuse,Alcohol Addiction,Alcohol Dependence,Alcohol Use Disorder,Abuse, Alcohol,Abuse, Ethanol,Addiction, Alcohol,Alcohol Use Disorders,Chronic Alcoholic Intoxication,Dependence, Alcohol,Intoxication, Chronic Alcoholic,Use Disorders, Alcohol
D012633 Secretin A peptide hormone of about 27 amino acids from the duodenal mucosa that activates pancreatic secretion and lowers the blood sugar level. (USAN and the USP Dictionary of Drug Names, 1994, p597) Secrepan,Secretin Citrate, Pig,Secretin Maleate, Pig,Secretin Pentacetate, Pig,Secretin Sulfate, Pig,Secretin, Pig,Secretin-KABI,Pig Secretin,Pig Secretin Citrate,Pig Secretin Maleate,Pig Secretin Pentacetate,Pig Secretin Sulfate,Secretin KABI,SecretinKABI

Related Publications

H Harada, and M Takeda, and H Yabe, and E Hanafusa, and T Hayashi, and K Kunichika, and F Kochi, and K Mishima, and I Kimura, and T Ubuga
January 1990, Gastroenterologisches Journal : Organ der Gesellschaft fur Gastroenterologie der DDR,
H Harada, and M Takeda, and H Yabe, and E Hanafusa, and T Hayashi, and K Kunichika, and F Kochi, and K Mishima, and I Kimura, and T Ubuga
January 1985, Sovetskaia meditsina,
H Harada, and M Takeda, and H Yabe, and E Hanafusa, and T Hayashi, and K Kunichika, and F Kochi, and K Mishima, and I Kimura, and T Ubuga
April 1983, The American journal of gastroenterology,
H Harada, and M Takeda, and H Yabe, and E Hanafusa, and T Hayashi, and K Kunichika, and F Kochi, and K Mishima, and I Kimura, and T Ubuga
January 1985, Khirurgiia,
H Harada, and M Takeda, and H Yabe, and E Hanafusa, and T Hayashi, and K Kunichika, and F Kochi, and K Mishima, and I Kimura, and T Ubuga
December 1981, Gastroenterologia Japonica,
H Harada, and M Takeda, and H Yabe, and E Hanafusa, and T Hayashi, and K Kunichika, and F Kochi, and K Mishima, and I Kimura, and T Ubuga
January 1978, Gastroenterologia Japonica,
H Harada, and M Takeda, and H Yabe, and E Hanafusa, and T Hayashi, and K Kunichika, and F Kochi, and K Mishima, and I Kimura, and T Ubuga
January 1993, Digestive diseases and sciences,
H Harada, and M Takeda, and H Yabe, and E Hanafusa, and T Hayashi, and K Kunichika, and F Kochi, and K Mishima, and I Kimura, and T Ubuga
April 1978, Klinische Wochenschrift,
H Harada, and M Takeda, and H Yabe, and E Hanafusa, and T Hayashi, and K Kunichika, and F Kochi, and K Mishima, and I Kimura, and T Ubuga
February 1978, Acta hepato-gastroenterologica,
H Harada, and M Takeda, and H Yabe, and E Hanafusa, and T Hayashi, and K Kunichika, and F Kochi, and K Mishima, and I Kimura, and T Ubuga
June 1981, Hepato-gastroenterology,
Copied contents to your clipboard!